Trending

Stories

Zydus Cadila Launches Generic Version of Remdesivir at Rs 2,800 Per Vial in India

Tidio Live Chat Software - Add Tidio live chat software to your website in minutes. Contact visitors and turn them into happy customers. Enhance their experience and boost your sales. Get it for Free

WP Rocket - WordPress Caching Plugin

Must Read

Drug firm Zydus Cadila on Thursday said it had launched a generic version of Remdesivir, used for treating patients suffering from severe COVID-19 symptoms, at Rs 2,800 per 100 mg vial in the Indian market.

Branded as Remdac, the drug is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.

Also Read

The company said the drug would be made available across India through the group’s distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19,” Cadila Healthcare Managing Director Sharvil Patel said.

Elegant Themes - The most popular WordPress theme in the world and the ultimate WordPress Page Builder. Get a 30-day money-back guarantee. Get it for Free

Through the course of this pandemic, the company’s efforts have been focused on supporting people in this healthcare crisis, whether it is through developing vaccines, ramping up production and distribution of critical drugs and therapies, making diagnostic tests available or exploring new treatment options, he added.

The drug’s active pharmaceutical ingredient (API) has been developed and manufactured at the group’s API manufacturing facilities in Gujarat, Zydus Cadila said.

It added that complete backward integration makes Remdac the most economical Remdesivir brand in India.

In June this year, Zydus had entered into a non-exclusive agreement with Gilead Sciences to manufacture and sell Remdesivir. This investigational drug has been issued an emergency use authorisation by the US Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of COVID-19, the filing said.

Zydus Cadila’s vaccine ZyCov-D is now in phase-II of clinical trials.

Zydus Cadila is the fifth company to have launched its generic version of Remdesivir in India. Hetero Labs, Cipla, Mylan and Jubilant Life Sciences have already launched their generic versions of antiviral drug Remdesivir in the country.

With a record single-day spike of 66,999 cases, India’s COVID-19 tally mounted to 23,96,637 on Thursday, according to the health ministry.

Shares of Cadila Healthcare, the listed entity of the Zydus group settled at Rs 385.90 per scrip on BSE, up 0.16 per cent from its previous close.

iThemes WordPress Hosting

Stay updated

Subscribe to our newsletter and never miss an update on the latest tech, gaming, startup, how to guide, deals and more.

Latest

Stories

- Advertisement -
- Advertisement -

Latest

Grow Your Business

Place your brand in front of tech-savvy audience. Partner with us to build brand awareness, increase website traffic, generate qualified leads, and grow your business.

- Advertisement -

Grow Your Business

Get these business solutions, tools and services to help your business grow.
Elementor

Elementor -Join 5,000,000+ Professionals Who Build Better Sites With Elementor. Build your website with 100% visual design that loads faster and speeds up the process of building them.

WP Rocket

WP Rocket - Speed up your website with the most powerful caching plugin in the world. The website speed increase means better SEO ranking, user experience, and conversation. It’s a fact that Google loves a fast site.

Kinsta

Kinsta - If you are looking for WordPress managed hosting, Kinsta is in the leading front. Kinsta provides WordPress hosting for a small or large business that helps take care of all your needs regarding your website with cutting-edge technology.

OptinMonster

OptinMonster - Instantly boost leads and grow revenue with the #1 most powerful conversion optimization toolkit in the world. 700,000+ websites are using OptinMonster to turn their traffic into leads, subscribers, and sales.

Related

- Advertisement -
- Advertisement -
India to Produce Upcoming iPhones: Trade Minister Japanese Professor Developed A Power Semiconductor made of Diamond Google Releases New Product for India’s Merchants Indian EV Startup Unveil Two AutoBalancing Electric Scooters OPPO Find X6 Pro Images Render via Weibo Sony Develops New Tech to Reduce Noise of Image Sensors Tesla’s S & Y Models Earn Best-in-Class Cars of 2022 India Approved $320m to Promote Homegrown Payments Network Twitter Roll Out TikTok-like ‘For You’ Timeline on iOS Nothing Phone Enters US with Beta Membership Program
Finally! Apple’s VR Headset Coming this Spring Harvard Scientists Develop New Cell Therapy to Kill, and Prevent Brain Cancer HTC Vive XR Elite VR/AR Headset Now Selling for $1099 Realme 10 Launched in India with Helio G99 Gaming Chipset Twitter Data Breach Revealing User’s Private Information Instagram New Feature to Create Albums With Friend Redmi Note12 Pro Plus Launched in India POCO C50 Launched in India